Navigation Links
Senior Executives of Cytyc Corporation, and Constitution Medical, Inc., Announce the Launch of ATON PARTNERS

BOSTON, Sept. 23, 2013 /PRNewswire/ -- Patrick Sullivan and Daniel Levangie, senior executives who led the emergence of Cytyc Corporation as a leading women's healthcare company and subsequently the formation of Constitution Medical, Inc., today announced the formation of ATON Partners, LLC.  Mr. Sullivan and Mr. Levangie formed ATON Partners to provide management advisory services to early stage medical device and in vitro diagnostic companies while evaluating investment opportunities within these areas of medical technology and product development.  Mr. Sullivan, former President and Chief Executive Officer of Cytyc Corporation, and Mr. Levangie, former Executive Vice President of Cytyc Corporation and President of Cytyc's Surgical Products Division, formed Constitution Medical Investors in Partnership with Warburg Pincus Private Equity in 2008 and subsequently built Constitution Medical, Inc.  Constitution Medical, Inc., developers of the Bloodhound Integrated Hematology System, was acquired by Roche Diagnostics in July 2013.

ATON Partners will provide advisory services to medical device and in vitro diagnostic companies where the principals will be able to leverage their product development, regulatory, clinical and commercial experience.  Over the course of 15 years at Cytyc, one of the leading companies focused on improving healthcare for women, Sullivan and Levangie led the executive team that grew Cytyc Corporation to approximately $700 million in annual revenues while establishing operations in 20 countries.

"Both Dan and I feel fortunate to have been able to lead the team that built Cytyc Corporation to its preeminent position in women's health, and more recently to have again led the talented CMI team as it developed the Bloodhound Integrated Hematology System.  With the integration of CMI with Roche Diagnostics now complete, we are excited to put our extensive experience to work in a new venture," said Mr. Sullivan.  "We are proud of our track record of success in creating value in the healthcare marketplace, and are looking forward to working with other talented management teams to provide guidance based upon our combined 50 years of experience in building great companies and significant shareholder value."

About ATON Partners, LLC
ATON Partners, LLC is a Boston-based private management advisory and investment firm focused on healthcare sector-related companies and technologies, led by Patrick Sullivan, formerly President and Chief Executive Officer of Cytyc Corporation and and Daniel Levangie, formerly Executive Vice President of Cytyc Corporation and President of Cytyc's Surgical Products Division.  ATON Partners focuses exclusively on companies involved in the development and commercialization of medical devices and in vitro diagnostics as well as investments in innovative, healthcare-related platform technologies and companies where the principals will be able to leverage their product development, regulatory, clinical and commercial experience.  For more information, visit  ATON Partners, LLC is located at 75 Arlington Street, Suite 500, Boston, MA 02116.

Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Trevena Appoints Roberto Cuca as Senior Vice President & Chief Financial Officer
2. New Research Finds Many Seniors Wrongly Think Public Health Insurance Exchanges Are Replacing Medicare Plans
3. Cyberonics Names Rohan J. Hoare, Ph.D. Senior Vice President, Strategic Planning
4. PRA Holdings Announces Proposed Private Offering of $375 Million Senior Notes Due 2023
5. Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
6. GeNO LLC Announces Senior Management Appointment
7. MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
8. TeraRecon Appoints Jeff Sorenson as Senior Vice President Sales and Marketing
9. Former Pfizer/Wyeth Global Infectious Disease Pharmaceutical Executive, Lewis Barrett, Appointed Senior Vice President, Commercial Strategy of Synthetic Biologics, Inc.
10. Actavis Announces New Senior Unsecured Term Loan Credit and Guaranty Agreement
11. Astellas Appoints New Senior Vice President of Global Oncology Development
Post Your Comments:
(Date:6/24/2016)... DUBLIN , June 24, 2016 ... addition of the "Structural Electronics 2015-2025: Applications, ... In-Mold Electronics, Smart ... Integrated Photovoltaics Structural electronics involves ... as load-bearing, protective structures, replacing dumb structures such ...
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... Diego, CA (PRWEB) , ... June 24, 2016 , ... ... with the American Cancer Society and the Road To Recovery® program to drive cancer ... to seniors and other adults to ensure the highest quality of life and ongoing ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. ... articles published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
Breaking Medicine News(10 mins):